RADICAL PERINEAL PROSTATECTOMY: ONCOLOGICAL OUTCOME DURING A 20-YEAR PERIOD

Abstract

Our study confirms our postulates. It also provides guidelines for comparing therapies among institutions and emphasizes that enthusiasm for new treatments may be based on insufficient followup. Patient selection may severely bias outcome independent of treatment when death is used as the end point. Our study establishes the value of PSA as a surrogate end point.